文献速递脊柱关节炎

共病对强直性脊柱炎和银屑病关节炎患者躯体功能的影响:风湿科门诊横断面研究

Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross-Sectional Study.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2020-05-14

该横断面研究基于心血管风湿病研究基线数据,纳入738例强直性脊柱炎(AS)和721例银屑病关节炎(PsA)患者,评估共病对躯体功能的影响。多变量模型显示,在PsA患者中Charlson共病指数替代指标(CCIp)与更差的躯体功能独立相关(β=0.11),而在AS患者中CCIp与躯体功能无独立关联。

要点

  • PsA患者中共病负担(CCIp)与更差的躯体功能独立相关(β=0.11)。
  • AS患者中年龄、疾病活动度、影像学损伤和生物制剂使用与更差功能独立相关,但CCIp无独立关联。
  • PsA患者中女性、病程、疾病活动度、NSAIDs、糖皮质激素和生物制剂使用与更差功能相关,高教育水平与更少残疾相关(β=-0.14)。

核心结论

  • 在PsA患者中,共病的存在与更差的躯体功能独立相关,检测和控制共病可能有助于疾病的整体管理。
  • 在AS患者中,共病负担(CCIp)未显示与躯体功能独立相关。

研究设计与样本

  • 横断面分析,基线数据来自心血管风湿病研究。
  • 纳入738例AS和721例PsA患者,21%的患者有>1种共病。
  • 采用多变量模型,以躯体功能(AS用BASFI,PsA用HAQ)为因变量,自变量包括CCIp(范围0-27)、社会人口学数据、疾病活动度(AS用ESR和BASDAI;PsA用基于ESR的DAS28)、病程、影像学损伤和治疗。

主要发现

  • PsA患者中,CCIp与更差的调整后躯体功能独立相关(β=0.11)。
  • PsA患者中,女性(β=0.14)、病程(β=0.01)、疾病活动度(DAS28-ESR;β=0.19)、使用NSAIDs(β=0.09)、糖皮质激素(β=0.11)和生物制剂(β=0.15)与更差功能相关;更高教育水平与更少残疾相关(β=-0.14)。
  • AS患者中,年龄(β=0.03)、疾病活动度(BASDAI;β=0.81)、影像学损伤(β=0.61)和使用生物制剂(β=0.51)与更差功能独立相关,但CCIp无独立关联。

关键数值与推荐

  • PsA患者中CCIp与躯体功能的β=0.11(多变量模型,因变量为HAQ)。
  • AS患者中BASDAI与躯体功能的β=0.81(多变量模型,因变量为BASFI)。
  • AS患者中影像学损伤与躯体功能的β=0.61(多变量模型,因变量为BASFI)。

临床怎么用

  • 对PsA患者应评估和管理共病,可能有助于改善躯体功能。
  • 对AS患者,控制疾病活动度和影像学损伤、合理使用生物制剂是改善功能的重要方面。
  • PsA患者中需关注女性、长病程、高疾病活动度及NSAIDs、糖皮质激素、生物制剂使用对功能的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the impact of comorbidities on physical function in patients with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). METHODS: This was a cross-sectional analysis of the baseline visit from the Cardiovascular in Rheumatology study. Multivariate models with physical function as the dependent variable (Bath Ankylosing Spondylitis Functional Index and Health Assessment Questionnaire for AS and PsA, respectively) were performed. Independent variables were a proxy for the Charlson Comorbidity Index (CCIp; range 0-27), sociodemographic data, disease activity (erythrocyte sedimentation rate [ESR] and Bath Ankylosing Spondylitis Disease Activity Index [BASDAI] in AS; Disease Activity Score in 28 joints [DAS28] using the ESR in PsA), disease duration, radiographic damage, and treatments. Results were reported as beta coefficients, 95% confidence intervals (95% CIs), and P values. RESULTS: We included 738 patients with AS and 721 with PsA; 21% of patients had >1 comorbidity. Comorbidity burden (CCIp) was independently associated with worse adjusted physical function in patients with PsA (β = 0.11). Also, female sex (β = 0.14), disease duration (β = 0.01), disease activity (DAS28-ESR; β = 0.19), and the use of nonsteroidal antiinflammatory drugs (β = 0.09), glucocorticoids (β = 0.11), and biologics (β = 0.15) were associated with worse function in patients with PsA. A higher education level was associated with less disability (β = -0.14). In patients with AS, age (β = 0.03), disease activity (BASDAI; β = 0.81), radiographic damage (β = 0.61), and the use of biologics (β = 0.51) were independently associated with worse function on multivariate analyses, but CCIp was not. CONCLUSION: The presence of comorbidities in patients with PsA is independently associated with worse physical function. The detection and control of the comorbidities may yield an integral management of the disease.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Fernández-Carballido C, Martín-Martínez MA, García-Gómez C, et al. Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross-Sectional Study. Arthritis Care Res (Hoboken). 2020. PMID: 31033231. doi:10.1002/acr.23910

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。